(Q44182990)

30 November 2017

Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice (English)

1 reference

30 November 2017

5

Brian Kobilka

1 reference

30 November 2017

Patricia C Brum

1

1 reference

30 November 2017

Jon Kosek

series ordinal

2

1 reference

30 November 2017

Andrew Patterson

series ordinal

3

1 reference

30 November 2017

Daniel Bernstein

series ordinal

4

1 reference

30 November 2017

1 November 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

30 November 2017

1 reference

30 November 2017

283

1 reference

30 November 2017

5

1 reference

30 November 2017

H1838-45

1 reference

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

The role of exercise-based prognosticating algorithms in the selection of patients for heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Is paradoxical pharmacology a strategy worth pursuing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Stress pathways and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Models of experimental hypertension in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Augmenting beta receptors in the heart: short-term gains offset by long-term pains?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Beta-adrenergic receptors and receptor signaling in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Value of exercise testing in assessing clinical state and prognosis in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Inhibition of spontaneous beta 2-adrenergic activation rescues beta 1-adrenergic contractile response in cardiomyocytes overexpressing beta 2-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01063.2001

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

The adrenergic nervous system in heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Molecular aspects of adrenergic signal transduction in cardiac failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Alterations in dynamic heart rate control in the beta 1-adrenergic receptor knockout mouse.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians-National Institutes of Health conference

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Chronic Sympathetic Suppression in the Treatment of Chronic Congestive Heart Failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Catecholamines, cardiac beta-adrenergic receptors, and heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.01063.2001

Identifiers

DOI

10.1152/AJPHEART.01063.2001

1 reference

release_j4izqpwzjnaeheu2wakdxesd3u

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4izqpwzjnaeheu2wakdxesd3u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference